Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today ...

NEWARK, CA / ACCESS Newswire / May 21, 2025 / Protagonist Therapeutics, Inc. (“Protagonist” or the “Company”) today announced ...

SAN DIEGO, May 23, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company ...

Ph.D., will provide a corporate update and engage in one-on-one investor meetings at the Jefferies Global Healthcare Conference from June 3-5, 2025, in New York City, with a presentation scheduled ...

Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference. The live presentation will take place on ...

today announced that Chief Financial Officer Sam Eldessouky is scheduled to participate in the 2025 Jefferies Global Healthcare Conference in New York City on June 4, 2025, at 7:35 a.m. ET.

will provide a corporate overview and participate in one-on-one investor meetings at the Jefferies Global Healthcare Conference, to be held in New York from June 3-5, 2025.

I-Mab will present clinical updates on givastomig at the Jefferies Global Healthcare Conference and share new data at ESMO 2025. I-Mab, a U.S.-based biotech company specializing in precision ...

Format: Presentation and one-on-one investor meetings Presentation Time: 4:55 p.m. ET Corbus Pharmaceuticals Holdings, Inc.

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Jefferies Global Healthcare ...

About the Company Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related ...